Targeted Cancer Therapies
Experimental RNAi
siRNA - Small Interfering RNAs
Tumor Immunotherapy
Mitogens and the Cell Cycle
Combination Therapies and Personalized Medicine
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 3, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH.
This study explores ex vivo gene therapy for cancer using insulin-like growth factor 1 (IGF-1) antisense RNA. This approach targets IGF-1
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: